PT  - JOURNAL ARTICLE
AU  - Zimmer, Alexandra S.
AU  - Nichols, Erin
AU  - Cimino-Mathews, Ashley
AU  - Peer, Cody
AU  - Cao, Liang
AU  - Lee, Min-Jung
AU  - Kohn, Elise C.
AU  - Annunziata, Christina M.
AU  - Lipkowitz, Stanley
AU  - Trepel, Jane B.
AU  - Sharma, Rajni
AU  - Mikkilineni, Lekha
AU  - Gatti-Mays, Margaret
AU  - Figg, William D.
AU  - Houston, Nicole D.
AU  - Lee, Jung-Min
TI  - A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1–3 inhibitor, cediranib, in recurrent women’s cancers with biomarker analyses
AID  - 10.1186/s40425-019-0680-3
DP  - 2019 Dec 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - 197
VI  - 7
IP  - 1
4099  - http://jitc.bmj.com/content/7/1/197.short
4100  - http://jitc.bmj.com/content/7/1/197.full
SO  - J Immunother Cancer2019 Dec 01; 7
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.